Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mycel

Explore full profile

Using technology to stimulate customers' imagination and help them transition to sustainable, closed-loop systems

South KoreaFounded 2020Food
Valuation $25–50M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Mycel and the history behind them.

About Mycel

Mycel, a South Korean biomaterials company, was established in 2020 as a spin-off from the Hyundai Motor Group. The company was co-founded by CEO Sungjin Sah. Mycel operates in the growing market for sustainable materials, which is projected to reach approximately $2.2 billion by 2026.

Read full description

The firm specializes in developing and producing bio-based materials derived from mycelium, the root-like structure of mushrooms. Its business model focuses on creating environmentally friendly alternatives to traditional materials for a diverse client base that includes the fashion, automotive, and cosmetics industries. Mycel also develops alternative proteins, positioning itself as a competitor to fungi-based food producers. The company generates revenue through business-to-business sales and collaborations with global brands to co-develop products.

Mycel's core product is a portfolio of fungal-based biomaterials. These materials can be manufactured to serve as substitutes for both leather and meat. The mycelium-based leather alternative is designed for applications in car seats, fashion accessories like shoes and bags, and luxury cosmetic product packaging. This material is noted for its durability and flexibility, which are comparable to animal leather. Unlike synthetic leathers that often rely on chemical blending, Mycel's process utilizes the natural intertwining properties of mycelium. For the food sector, the company produces a mycoprotein that offers a meat-like texture and is white and odorless, making it a versatile ingredient for a variety of food products. The production process for these biomaterials uses significantly less water and produces fewer carbon emissions compared to animal-based material processing.

In August 2022, Mycel secured $10 million in a pre-Series A funding round from investors including Korea Development Bank, Industrial Bank of Korea, and Hyundai Motor's Zero 1 Fund, which brought the company's pre-money valuation to approximately $40 million. This capital was allocated to establish a production plant in South Korea to scale up manufacturing and to expand the team. The company aimed to commercialize its mushroom leather in 2023 and has plans to enter the Singapore market with its alternative protein products. Keywords: mycelium, biomaterials, alternative leather, alternative protein, mycoprotein, sustainable materials, Hyundai spin-off, biotech, circular economy, fungi-based products, biomanufacturing, eco-friendly materials, Sungjin Sah, Anolea, vegan leather, food tech, material science, green technology, cleantech, South Korean startup

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
South Korea
Employees
7
Open positions
None listed
Dealroom signal
61.3/100
Industry
Food
Sub-industry
AgriTech
Sector
Food, Biotechnology, Sustainable Development Goals, Mycelium Technology, Biotechnology in Food, Climate Tech, B Corp
Business model
Manufacturing
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Aug 2022 $10M $40M Korea Development Bank · Spring Camp · Stone Bridge · Hyundai Motor Company ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Mycel website traffic

Latest recorded traffic for Mycel is 1.9K monthly website visits, up 123.5% over the last three months. Mycel's team declined 12.5% over the past year.

Latest monthly visits1.9K 3-month web change+123.5% 1-year team growth-12.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • Korea Development Bank
  • Spring Camp
  • Stone Bridge
  • Hyundai Motor Company
  • We Ventures
  • Industrial Bank of Korea

Other known investors1 additional known investor

  • Springcamp
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇰🇷 South Korea100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mycel on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mycel’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.